Effects of Ursodeoxycholic Acid Treatment for Intrahepatic Cholestasis of Pregnancy on Maternal and Fetal Outcomes

作者
Madiha Iqbal,Zia Muhammad,Naheed Akhter,Samina Shams Alam
出处
期刊:Cureus [Cureus, Inc.]
卷期号:16 (10): e70800-e70800 被引量:4
标识
DOI:10.7759/cureus.70800
摘要

BACKGROUND: Intrahepatic cholestasis of pregnancy (ICP) appears in the second or third trimester of pregnancy and is characterized by pruritus and elevated blood bile acid (BA) levels. Complications from these symptoms may include preterm birth, fetal distress, or stillbirth. Although the precise causes of ICP are unknown, genetic, hormonal, and environmental variables may be involved. First-line treatment for ICP is ursodeoxycholic acid (UDCA), which improves bile flow and consequently lowers BA levels and pruritus. OBJECTIVE: The objective of this study is to investigate the impact of UDCA therapy on maternal and fetal outcomes in women with ICP. MATERIALS AND METHODS: This was a prospective observational study of 123 pregnant women with ICP, aged between 20 and 45 years who were diagnosed clinically (pruritus) supported by abnormal laboratory results including elevated serum BA levels, and abnormalities in liver function tests, over the course of three years, from July 2021 to June 2024. Every patient received UDCA, commencing at 10-15 mg/kg/day and being titrated according to clinical guidelines. Maternal and fetal outcomes were tracked for the duration of the pregnancy, with data being collected at baseline (15 ± 1 weeks) and every two weeks until delivery. RESULTS: The mean age of the study participants was 29.6 ± 5.4 years, with the youngest patient being 20 years and the oldest being 45 years. Most women were multipara 65.9%, and the mean BMI was 27.8 ± 3.5 kg/m ². The mean time of gestational age at ICP diagnosis was 31.2 ± 2.7 weeks, and the time of gestational age at delivery was 37.1 ± 2.4 weeks. On average, the serum BA level at diagnosis was 23.5 ± 8.1 µmol/L. CONCLUSION: In the majority of ICP patients with good fetal outcomes, UDCA not only normalizes serum BA levels but also reduces maternal symptoms. In addition to addressing patient response variability to this therapy and optimizing dissemination procedures, the researchers expect that the results of this study will support the continued use of UDCA as first-line treatment for ICP, at least until more evidence becomes available.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
笑点低薯片完成签到,获得积分10
2秒前
小马甲的应助被调皮钧采纳,获得10
2秒前
雅2018完成签到 ,获得积分10
3秒前
3秒前
能干发卡完成签到,获得积分10
3秒前
zqq完成签到,获得积分10
3秒前
郗超悦完成签到,获得积分10
4秒前
SciGPT的应助被学术小白采纳,获得10
4秒前
英姑的应助被笑点低薯片采纳,获得10
5秒前
夏弱完成签到,获得积分10
6秒前
高级的百香果完成签到,获得积分10
7秒前
April完成签到,获得积分10
7秒前
JamesPei的应助被Alexlovar采纳,获得30
8秒前
8秒前
青山白鸟完成签到 ,获得积分10
9秒前
9秒前
YDB发布了新的文献求助10
9秒前
10秒前
10秒前
充电宝的应助被三十六采纳,获得10
10秒前
D_DAY发布了新的文献求助10
10秒前
科研通AI2S的应助被只因采纳,获得10
11秒前
12秒前
fiveby完成签到 ,获得积分10
12秒前
jean发布了新的文献求助10
13秒前
彭于晏的应助被思恩Shen采纳,获得10
13秒前
Lars发布了新的文献求助10
13秒前
fanfan完成签到,获得积分10
14秒前
李妍发布了新的文献求助80
14秒前
小古完成签到,获得积分10
15秒前
PEACE发布了新的文献求助10
16秒前
16秒前
17秒前
17秒前
19秒前
fishss完成签到,获得积分0
20秒前
MADAO发布了新的文献求助30
20秒前
Nidhogg完成签到,获得积分20
21秒前
852的应助被俭朴钢铁侠采纳,获得10
21秒前
那地方完成签到,获得积分0
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621